DrugPatentWatch Database Preview

Dialysis Sups Company Profile

« Back to Dashboard

What is the competitive landscape for DIALYSIS SUPS, and what generic alternatives to DIALYSIS SUPS drugs are available?

DIALYSIS SUPS has one approved drug.

There is one US patent protecting DIALYSIS SUPS drugs.

There are four patent family members on DIALYSIS SUPS drugs in four countries and thirteen supplementary protection certificates in seven countries.

Summary for Dialysis Sups

International Patents:	4
US Patents:	1
Tradenames:	2
Ingredients:	1
NDAs:	1

Drugs and US Patents for Dialysis Sups

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dialysis Sups	NORMOCARB HF 35	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-002	Jul 26, 2006		RX	Yes	Yes
Dialysis Sups	NORMOCARB HF 25	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-001	Jul 26, 2006		RX	Yes	Yes	7,300,674		Y

Expired US Patents for Dialysis Sups

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dialysis Sups	NORMOCARB HF 25	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-001	Jul 26, 2006	5,945,449
Dialysis Sups	NORMOCARB HF 35	magnesium chloride; sodium bicarbonate; sodium chloride	SOLUTION;INJECTION	021910-002	Jul 26, 2006	5,945,449

International Patents for Dialysis Sups Drugs

Country	Document Number	Estimated Expiration
Canada	2365787
European Patent Office	1347795
Australia	2620902
World Intellectual Property Organization (WIPO)	0249693

Supplementary Protection Certificates for Dialysis Sups Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
12/048	Ireland		PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
2012 00035	Denmark		PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
00517	Netherlands		PRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812
C/GB01/006	United Kingdom		PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
C0055	France		PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
2012000017	Germany		PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
0483	Netherlands		PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Dial
• Dialysis Sups